Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Research Priorities Priority studies should include rigorous human PK (multiple routes, dose proportionality), double blind placebo controlled dose ranging Phase II trials for a single indication (e.g
the commercial product (Geref) was voluntarily discontinued in 2008 for commercial reasons, not safety concerns, and the FDA confirmed the withdrawal was not due to efficacy or safety failures
Research demonstrates its remarkable ability to promote healing of muscles, tendons, ligaments, and even the gut lining
[12] It even helped to increase mobility in chronically stressed rats in that study
Nature 610:783790 Lardhi A, Ali RA, Ali R, Mohammed T (2018) Thalassemia minor presenting with vitamin B12 deficiency, paraparesis, and microcytosis
